Observational Study of Thenar NIRS in Pediatric Heart Failure
This observational study is looking at how a non-invasive device, the InSpectraTM StO2 monitor, measures oxygen levels in the hand (thenar eminence) of children with heart failure. The study aims to understand the baseline oxygen saturation (StO2) in these patients. You might be able to join if you are under 25 years old, have heart failure due to cardiomyopathy, myocarditis, or univentricular palliation for congenital heart disease, and are stable on your current medical treatment. The study is currently enrolling participants, with a goal of 130 patients.
- Study design
- This is a single-center, non-randomized observational study. It aims to enroll 130 participants.
- What's involved
- You would have a non-invasive probe placed on your hand to measure oxygen levels, followed by a blood pressure cuff inflation and release to measure changes in oxygen. This would happen on the day of your evaluation.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary measurement for this study is taken on Day 1.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Dipankar Gupta, MD · PRINCIPAL_INVESTIGATOR · University of Florida
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Baseline StO2 percentageDay 1
The study staff will use the InSpectraTM StO2 monitor manufactured by Hutchinson Technology to measure the baseline StO2 level after applying the noninvasive probe to the thenar eminence